Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.

Yang J, Xie R, Krewski D, Wang Y, Walker M, Cao W, Wen SW.

Chin Med J (Engl). 2014;127(4):702-6.

2.

Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.

Yang T, Walker MC, Krewski D, Yang Q, Nimrod C, Garner P, Fraser W, Olatunbosun O, Wen SW.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):270-7. doi: 10.1002/pds.1538.

PMID:
18181228
3.

Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.

Wen SW, Yang T, Krewski D, Yang Q, Nimrod C, Garner P, Fraser W, Olatunbosun O, Walker MC.

J Perinatol. 2008 May;28(5):324-9. doi: 10.1038/jp.2008.6.

PMID:
18288118
4.

Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.

Yang J, Xie RH, Krewski D, Wang YJ, Walker M, Wen SW.

Int J Infect Dis. 2011 May;15(5):e336-41. doi: 10.1016/j.ijid.2011.01.007.

5.

National patterns of medication use during pregnancy.

Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, Xue Z.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):537-45.

PMID:
16700083
6.

Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy.

Yang T, Walker MC, Krewski D, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, Wen SW.

Acta Obstet Gynecol Scand. 2007;86(11):1310-6.

PMID:
17963058
7.

Physician characteristics and prescription drug use during pregnancy: a population-based study.

Weng SS, Chen YH, Lin CC, Keller JJ, Wang IT, Lin HC.

Ann Epidemiol. 2013 Feb;23(2):54-9. doi: 10.1016/j.annepidem.2012.11.007.

PMID:
23218810
8.

Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).

Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG.

Clin Ther. 2012 Jan;34(1):239-249.e2. doi: 10.1016/j.clinthera.2011.11.025.

PMID:
22169049
9.

Prescription drug use in pregnancy.

Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R.

Am J Obstet Gynecol. 2004 Aug;191(2):398-407.

PMID:
15343213
10.

Prescriptions for category D and X drugs during pregnancy in Taiwan: a population-based study.

Kao LT, Chen YH, Lin HC, Chung SD.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1029-34. doi: 10.1002/pds.3599.

PMID:
24578346
11.

Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare.

Cooper WO, Hickson GB, Ray WA.

Paediatr Perinat Epidemiol. 2004 Mar;18(2):106-11.

PMID:
14996249
12.

Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland.

Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM.

Drug Saf. 2010 Jul 1;33(7):593-604. doi: 10.2165/11532330-000000000-00000.

PMID:
20553060
13.

Prescription of drugs during pregnancy in France.

Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL.

Lancet. 2000 Nov 18;356(9243):1735-6.

PMID:
11095263
14.

Use of prescription medications with a potential for fetal harm among pregnant women.

Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):546-54.

PMID:
16586470
15.

Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.

Kebede B, Gedif T, Getachew A.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):462-8. doi: 10.1002/pds.1732.

PMID:
19334033
16.

Correlates of prescription drug use during pregnancy.

Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M, Haas JS.

J Womens Health (Larchmt). 2005 Jun;14(5):401-9.

PMID:
15989412
17.

Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group.

Olesen C, Sørensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH.

Acta Obstet Gynecol Scand. 1999 Sep;78(8):686-92.

PMID:
10468060
18.

Health care provider attitudes and practices related to intrauterine devices for nulliparous women.

Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA.

Obstet Gynecol. 2012 Apr;119(4):762-71. doi: 10.1097/AOG.0b013e31824aca39.

PMID:
22433340
19.

Drug use before and during pregnancy in Serbia.

Odalovic M, Vezmar Kovacevic S, Ilic K, Sabo A, Tasic L.

Int J Clin Pharm. 2012 Oct;34(5):719-27. doi: 10.1007/s11096-012-9665-8.

PMID:
22744842
20.

Drug prescription in pregnancy: analysis of a large statutory sickness fund population.

Egen-Lappe V, Hasford J.

Eur J Clin Pharmacol. 2004 Nov;60(9):659-66.

PMID:
15480609
Items per page

Supplemental Content

Support Center